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Towards a More Holistic Understanding of  
American Support for Genetically Modified Crops:  
An Examination of Influential Factors Using a Binomial Dependent Variable 
 
ABSTRACT. This paper is an investigation into the relative importance of a wide variety of 
factors in influencing whether members of the American public support or oppose the use of 
biotechnology in agriculture and food production.  To accomplish this end, as well as to facilitate 
the examination of a large number of independent variables simultaneously, several statistical 
methods, including factor analyses, instrumental variables analysis, and probit and logistic 
regressions were performed.  It was determined that people’s perceptions of risks and moral 
acceptability were important contributors to opinion formation in this regard.  The effects of 
expected benefits, feelings of trust in information, and knowledge about biotechnology and 
genetics, were also investigated and found to exert varying levels of influence depending on the 
identity of the expected beneficiary or information source, as well as the kind of knowledge 
under consideration.  The roles of religious and political party affiliation were also examined and 
determined to be significant. 
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Introduction 
  Innovations in biotechnology have transformed what was once the stuff of science fiction 
into a part of our everyday lives.  Although traditional cross-breeding techniques are still 
employed, they are quickly being surpassed in importance by methods of direct genomic 
manipulation.  Multi-national life science companies, the majority of which are based in the 
United States, employ genetic sequencing and polymerase chain reactions to identify stretches of 
DNA that code for a desired trait, then isolate and replicate them directly, often in bacterial host 
cells.  The newly generated molecules are then transfected (most often using “gene guns”) into 
the nucleus of recipient plant cells, which are cultured to produce entirely new varieties of crops.   
Such processes, and the products they yield have inspired widely varying reactions 
among members of the public and governmental officials.   While some nations have launched 
vehement opposition to the proposed introduction of genetically modified crops onto their 
farmlands and dinner tables, others have provided little resistance to such efforts.  Given such 
varied reactions, one is left to wonder, “What factors are important in the formation of public 
opinion regarding GM foods?” and “What leads people to support this technology and its 
products?”    
  To answer these questions, a series of statistical analyses were performed on data 
gathered from 985 participants in the United States Biotechnology Survey, which was conducted 
between 1997 and 1998.  Responses to the question, “Do you support or oppose the use of 
biotechnology in agriculture and food production?” were examined using probit and logistic 
regressions, so as to determine the effect of a variety of personal characteristics and beliefs, 
thought to influence opinion formation in this regard.   The factors considered included measures   4
of knowledge, as well as trust in information about biotechnology, perceptions of risks and 
benefits, moral acceptability of genetically modified foods, political party affiliation, gender and 
religiosity.   
In addition to investigating the effects of some characteristics that have not previously 
been included in analyses of this type, this work is set apart from previous endeavors through the 
use of factor analysis and a two-stage regression.  These procedures were performed in order to 
reduce the (substantial) number of original predictor variables to a more manageable number, to 
uncover their underlying similarities between them, and to account for conceptual overlaps 
between the many elements thought to influence levels of support.  The new variables which 
resulted from these manipulations not only satisfied these technical goals, they also allowed for 
the discrimination of new and interesting relationships between the independent variables, and 
people’s levels of support for GM foods. 
  Most of the perceptions and conditions thought at the outset to be significant contributors 
to opinion formation were found to be important, however, the magnitudes of their individual 
effects on people’s feelings of support were far from equivalent.  Important distinctions were 
uncovered between the influences of various kinds of knowledge, benefits and trust.  For 
example, while benefits accruing to the respondent and their family were found to be significant, 
those affecting others were not.   
  In the pages that follow, the reader will be introduced to many of the issues surrounding 
GM foods in the United States.  Some parallels will be drawn with conditions in Europe and 
elsewhere, however, given that the data were collected from American respondents, this 
introductory discussion is designed to acquaint the reader with conditions as they are   5
experienced by this group.  A description of the factors thought to influence levels of support 
among members of the public is then provided, followed by a description of the data and 
methods employed throughout the analyses.  Finally, the results are presented and interpreted, 
and areas of possible future research enumerated.  
  
Background 
  The techniques of modern biotechnology, among them animal cloning, human genetic 
testing, and the creation of novel foods through direct genomic manipulation, have been heralded 
by some as the most important and promising innovations of the modern era.  To others, 
however, they represent a veritable Pandora’s box; a dangerous example of man’s propensity to 
tamper with forces beyond his understanding, without due regard for the potentially devastating 
consequences of such actions. (Beckwith, 2003)  Since the first experiments involving the 
sequencing and manipulation of DNA in the 1970s, debates have occurred as to moral and 
ethical acceptability of efforts to master the molecules through which life itself is encoded. 
(Ervin et al., 2000; Lassen et al., 2002) 
  In the U.S., policies designed to encourage the research and development of novel traits 
in crop plants abound.  Existing patent law, which was originally intended to provide motivation 
to would-be inventors by granting “ownership” over one’s innovations, has been used by those in 
the biotech industry to acquire legal rights, not only to newly-developed processes and 
equipment, but to plant species and even to entire genera. Companies’ ability to “patent life” 
raises moral and ethical questions for some, and may have the effect of encouraging the 
development of highly profitable crop varieties instead of those that would produce the greatest   6
benefits for society as a whole. (Ervin, 2000; Warner, 2001)    
Originally overseen by the National Institutes of Health’s Recombinant DNA Technology 
Committee, the extensive investments and research into genetically modified crops commanded 
executive attention and in 1984, when Reagan’s White House Office of Science and Technology 
Policy published “The Coordinated Framework for the Regulation of Biotechnology.” (Vogt, 
1999) The Framework was significant in that it established the premise upon which all future 
regulation of GM crops in the U.S. would be based; namely that it was the products, not the 
processes of biotechnology that would be subject to review and approval.  
The Framework’s guiding assumption was that products derived through the processes of 
modern biotechnology are not substantially different from their conventional counterparts.  
Hence, no new legislation was deemed necessary to regulate the development, cultivation and 
distribution of GMOs.  Instead, regulatory and oversight responsibilities were divided between 
three federal agencies concerned with the protection of environmental, food, and human health 
and safety: the Environmental Protection Agency (EPA), the U.S. Department of Agriculture 
(USDA) and the Food and Drug Administration (FDA).
1   (Harlander, 2002; Vogt, 1999)    
The resulting federal regulatory dynamic has been criticized as granting large multi-
national life science companies such as Dupont and Monsanto too much autonomy. (Ervin et al., 
2000)  The costs and the level of expertise required to perform independent testing of newly-
created cultivars have proven prohibitively high, forcing the EPA, FDA and USDA to rely 
almost exclusively on industry for the provision of information utilized throughout the approval 
process.  Regulators often check the materials submitted by applicants against their own body of 
knowledge, acquired through years of research and testing of conventional crops and pesticides,   7
yet some outside of government and industry have expressed dissatisfaction with this admittedly 
limited approach.  Fast-track approval systems, which allow for field testing to begin within as 
few as 30 days of filing for approval, and often permit new products to enter the market without 
a formal review of their safety for human consumption, have also been implemented. (Ervin et 
al., 2000; Vogt, 1999)   
Since their commercial introduction in 1996, GMOs have become a ubiquitous 
component of America’s food supply.  The number of acres in the U.S. dedicated to the 
cultivation of GM crops far outstrips that of any other nation, accounting for about 63 percent of 
all such agriculture globally in 2003.  Fully 85 percent of U.S. soybeans, 76 percent of the 
cotton, and 45 percent of the corn grown in that year were genetically modified cultivars. 
(NASS, 2003)  Because the U.S. lacks an established system of identity preservation,
2 
genetically modified foodstuffs, once harvested, are routinely intermingled with non-GM crop 
varieties. (Vogt, 1999)  As a result, many widely-available and commonly-consumed foods 
contain some GM components; this is especially true of processed foods and it is estimated that 
between 70 and 85 percent of such products contain ingredients derived from GM corn or soy.  
There is no way for consumers to discern which products contain GM ingredients however, 
because as they are considered “substantially equivalent” to conventional foods, the FDA has 
ruled that product labels are not required to divulge the presence of such contents.  (Harlander, 
2002) 
The regulatory and market dynamics, which facilitate the widespread cultivation and 
consumption of GM crops in the United States, are quite different than those that have developed 
in other nations.  When confronted with the issue of allowing GM seeds and food products to be   8
cultivated and consumed within their borders, many other nations, most notably the members of 
the European Union (EU), have launched considerable opposition. Citizens have taken to the 
streets in protest, and those in power have enacted trade embargos and labeling requirements. 
(Ervin et al., 2000; Gaskell et al., 1999; Besley et al., 2005; Lassen, et al., 2002.; Levidow, 2001; 
Harlander, 2002; Walker et al., 2000)   Clearly, the regulatory agencies and citizens in the U.S. 
have adopted a much more supportive stance with regard to this issue.  While some protests have 
occurred, they have been relatively few in number and have not prompted significant levels of 
governmental intervention. (Lassen, et al., 2002; Harlander, 2002.)  Given the intense and often 
intractable disagreements which have erupted in other countries regarding the introduction of 
genetically modified foodstuffs, why then have they managed to find their way onto Americans’ 
dinner plates with relatively little resistance?  
Previous Research 
  Despite receiving a great deal of attention from researchers, gaining a complete 
understanding of American’s feelings with regard to GM foods has proven difficult.  Even 
attempts aimed at simply gauging the national mood in this regard have produced different, 
sometimes conflicting results.  While some have purported that U.S. citizens are largely opposed 
to this use of technology, others have found significant levels of support. (Besley et al., 2005; 
The Mellman Group, 2005; Priest, 2000) 
The tendency to consider multiple, and arguably, quite different applications of modern 
biotechnology simultaneously (such as cloning, genetic testing and GM crops
3), may be partly to 
blame for the lack of conclusive findings. (Besley, et al., 2005)  Although similar in that they all 
involve the manipulation of genetic material, and are conducted by large multi-national life   9
science companies, the myriad applications which fall under the umbrella term of 
“biotechnology” are quite different in their goals, potential consequences and ethical 
implications.  These dissimilarities are likely important factors in the formation of opinions 
among members of the general public, especially in instances where their factual understanding 
of the techniques in question is limited. (Besley et al., 2005; Frewer et al., 1997; Gaskell et al., 
1999; The Mellman Group, 2005; Lassen 2002)  To avoid such confounding effects, the current 
analysis is confined to understanding people’s support for, or opposition to, GM crops. 
Previous attempts at identifying what contributes to people’s feelings about 
biotechnology have highlighted three general factors as among the most influential.  They 
include people’s perceptions of the associated risks and benefits, trust in manufacturers, 
regulators and the media, and their individual knowledge of the subject matter.  (Beckwith, et al., 
2003; Gaskell et al., 1999; Lassen et al., 2002; Poortinga et al., 2005; Priest, 2000; Savadori et 
al., 2004; Wilson et al., 2004)  While it appears that consensus has settled (at least for the 
moment) on the salience of these issues in opinion formation, the exact nature of their influence, 
as well as their relative importance, have not been clearly identified.  
The level of understanding an individual possesses regarding a technological process and 
its outputs can influence whether they perceive it to be worthwhile.  A lack of scientific 
understanding on the part of the lay public has often been cited as primarily responsible for the 
opposition, and inflated perceptions of risk sometimes observed with regard to new technologies. 
(Beckwith et al., 2003; Hohenemser, 1983; Fischhoff, 1978; Slovic, 1991 and 1987)  
In recent years, several large-scale studies have been conducted to determine Americans’ 
knowledge of the processes and products of biotechnology, as well as its regulation.  The   10
conclusion of these undertakings has been that the public remains largely uninformed however, 
the impacts of this lack of understanding are not altogether clear. (Beckwith et al., 2003; Bucchi, 
2002; The Mellman Group, 2005; Wilson et al., 2004)   Some have observed that better-informed 
individuals tend to me more supportive of foods produced through genetic modification, while 
others concluded that the opposite is in fact the case. (Bucchi, 2002; Wilson, 2004)   
The trust that members of the public have in regulators and producers of new 
technologies, and of GM foods specifically, as well as people’s confidence in the media outlets 
through which relevant information is disseminated, have also been found to be critical in 
shaping people’s perceptions and levels of support.  (Besley et al., 2005; Gaskell et al., 1999; 
Nisbet et al., 2001; Poortinga et al., 2005; Seigrist et al., 2000)  Foods are “credence goods,” a 
designation that reflects the fact that purchasing decisions are always characterized by some 
degree of uncertainty. (Phillips, et al., 1998)   This uncertainty stems from consumers’ inability 
to independently verify claims made about the products (such as caloric content, ingredients, 
etc.) either before or after purchase.  When trust in the producers and the relevant regulatory 
agencies is high, decisions about whether to buy and/or consume a particular product are 
simplified, thereby increasing the likelihood of such outcomes. (Savadori et al., 2004)   
Generally speaking, the higher the level of trust in relevant institutions and individuals, 
the greater the level of support for GM technology, yet measures of trust have differed across 
studies. (Gaskell et al., 2004; James, 2003; Poortinga et al., 2004; Savadiri et al., 2004; Siegrist, 
2000)  Two related, but fundamentally different types of trust are relevant with regard to GM 
foods: trust in “overall hazard management” and trust in information sources. (Savadori et al., 
2004)  The former concerns how confident people are that all necessary precautions are being   11
taken, and that any unexpected negative consequences can be dealt with effectively.  The 
measures of trust considered here however, are of the latter variety; what Savadori et al. refer to 
as “source credibility.”   
Perhaps the best researched relationship with regard to people’s perceptions of GM foods 
has been that between risk perception and levels of support.  It is widely accepted that the greater 
the risk something is thought to pose, the less likely it is to enjoy widespread support.  In light of 
this relationship, the method by which members of the public judge the inherent riskiness of 
complex and recently-developed technologies (such as those of modern bioengineering) has been 
the subject of extensive research.  The general conclusion of these investigations has been that 
members of the public consider risk through fundamentally different lenses than do scientists and 
others who have received professional training in fields relevant to the technology under 
consideration. Experts are thought to conduct what have been deemed “rational” risk 
assessments, which involve quantifying the hazard and the likelihood of a negative consequence 
occurring, and then assessing its possible ramifications.  The average citizen however, relies not 
on such methodical thought processes, but instead depends heavily on heuristics in judging the 
magnitude and severity of potential risks.  (Siegrist, 2000; Savadori et al., 2004, Hohenemser et 
al., 1983; Slovic, 1987 & 1991)    
The now-famous “psychometric paradigm” of risk perception developed by Paul Slovic 
and Baruch Fischhoff is the taxonomic scheme which has been used as a conceptual starting 
point for considering lay people’s reactions to biotechnology. (Bolohm, 1998; Gaskell et al., 
2004)  The paradigm breaks risk perception into two essential components, “dread risk” and 
“unknown risk,”
 4 which are based upon a set of measures developed by Chauncey Starr in   12
attempt to answer the question “How safe is safe enough?” with regard to technological risks. 
(Fischhoff, 1978; Slovic, 1987)  It has been determined that participants experienced a high level 
of “dread risk” and a moderately high level of “unknown risk” when thinking about DNA 
technology. These ratings closely resemble those reported for nuclear power, a technology which 
is often cited as among the most dreaded and hence, least popular of modern man’s 
accomplishments. (Priest, 2000; Savadori et al, 2004; Slovic 1991)   
A condensed set of the factors upon which the psychometric paradigm is constructed has 
been identified by Peter Sandman and others as the most influential in causing the public to 
become outraged, a condition which serves to heighten risk perceptions.  Voluntariness is 
arguably the most important of these factors, hence, the less able people are to avoid assuming a 
particular risk if they so choose, the more likely they are to become outraged.  Since foods 
containing GM products are not required to display labels divulging this fact, it could be argued 
that any potential risks associated with their consumption are largely assumed involuntarily.  
Controllability is also critical because the more influence the individual believes to exert over a 
potential hazard, the less risky it seems.  Whether risks accrue disproportionately to some 
individuals also contributes to outrage, as does the process by which decisions concerning the 
risk are made by those in power.
5 (Sandman, 1987; Beckwith, 2003) Some have suggested that 
for this reason, the decision by manufacturers to target their efforts towards designing crops 
whose benefits
6 are realized by producers rather than consumers is largely to blame for 
opposition to such products observed among members of the general public. (Walker et al., 
2000)     13
The moral acceptability of a hazard can also influence the level of risk it is thought to 
pose, as does its familiarity.  The latter characteristic is also related to another of Sandman’s 
outrage factors, namely “memorability,” because while familiar hazards often appear to be less 
risky than unfamiliar ones, those which can be linked to a memorable and horrific event (such as 
three mile island) or symbol (for example, an oiled sea bird), are perceived as higher risk than 
those without such connotations.  The level of dread associated with a hazard can also make it 
appear more or less risky.
7  Finally, the distribution of effects across time and space is also 
influential with negative outcomes that are concentrated in duration and area creating greater 
outrage than more dispersed ones.
8 (Sandman, 1987)   
Clearly then, risk perception is not a unique category of analysis that can be neatly and 
singularly incorporated into an equation aimed at determining the factors that influence people’s 
decisions to either support or oppose the use of biotechnology in food production and 
agriculture.  Rather, notions of hazard and risk are fundamentally linked to, and defined by, 
many of the other factors thought to be important in this regard. (Seigrist et al., 2000; Boholm, 
1998; Sandman, 1987)  Previous researchers have recognized the existence of this dynamic, and 
although efforts have been directed towards identifying and describing this delicate interplay of 
issues and perceptions, much remains unresolved. 
Closely linked to people’s perception of risk is that of benefit.  There is widespread 
agreement that the comparison of expected gains and losses lies at the heart of feelings of 
support or opposition, the former occurring in instances where the positive outcomes are 
expected to outweigh the negative. (Fischhoff, 1978; Hohenemser, 1983; Savadori et al., 2004; 
Wilson et al., 2004)  It has been suggested that people consider benefits at the outset and only   14
think about risks after having concluded that substantial gains could result from a given action.  
This, they say, is the Achilles heal of foods produced through biotechnology because members of 
the general public do not see the advantages afforded through such techniques as being 
appreciably greater than those produced through traditional methods. (Gaskell, 2004)   
It is also possible that people do not consider benefits and risks in any predetermined 
order, or that some, but not all members of the public make use of such a linear thought process.  
For those who are particularly risk averse, consideration of risks may occur before that of 
benefits, while others may compare the magnitude of both the positives and the negatives 
simultaneously.  Efforts to describe the effects of perceived benefits and risks on opinions related 
to technical hazards, have yet to produce a definitive description of the reasoning involved, a fact 
which likely reflects the highly individualized nature of the processes employed by members of 
the public. (Salvadori et al., 2004) 
Although their influences have not been as completely explored as have those of 
knowledge, trust and risk/benefit perceptions, people’s feelings as to whether the processes and 
products of biotechnology are morally acceptable, as well as their personal political ideology, 
have been found to influence levels of support.  Previous research indicates that those who 
perceive this use of technology to be morally sound are more likely to feel supportive of such 
endeavors, and it has been found that, while morality is conceptually linked to assessments of 
risk, it also exerts some independent effect in determining levels of support. (Gaskell et al., 1999; 
Lassen, 2002)  Political ideology is also an important individual characteristic in this regard.  
Those who are more liberal-minded tend to be less supportive of biotechnology, than are more 
conservative individuals. (Besley et al., 2005)    15
Differences in perceptions of biotechnology across gender lines have also been 
investigated.  While not all studies have found respondents’ sex to be a significant determinant of 
support, in those instances where its effect was influential, males were more supportive than 
females.  This disparity is thought to arise from the fact that women tend to be more risk averse 
than men, a characteristic linked to decreased support for undertakings that have the potential to 
produce negative outcomes, in addition to their promised benefits. (Besely et al., 2005; James, 
2003; Savadori, 2004; Siegrist, 2000) 
Data and Methods 
  The data utilized for this analysis were taken from the United States Biotechnology 
Study, which was conducted between November 1997, and February 1998.  The survey was 
administered via telephone and utilized random digit dialing to eliminate selection bias.  A total 
of 1,067 people completed the survey.  Both genders were about equally represented (females 
comprised about 50.2% of the sample), and the average age was 45.   Respondents were queried 
as to their knowledge and opinions of modern biotechnology, their interest in recent scientific 
innovations and news events, their level of trust of government, industry and educational 
institutions, and a variety of other issues, many of which are considered here.    
  The object of the current analysis was to determine which factors lead members of the 
public to either support or oppose the use of biotechnology in agriculture and food production.  
Some previous research that focused on elucidating this relationship chose to represent support 
using a hybrid dependent variable, composed of measures of respondents’ opinions as to whether 
this technological application can be considered “useful,” “morally acceptable” and “should be 
encouraged.” (James, 2003) Such a composite metric was not constructed for this analysis,   16
however, because the instrument used to gather the data included a question that directly asked 
survey takers whether they support this technological application.  Participants were offered two 
response categories in conjunction with the question of interest (“support” and “oppose”), 
therefore, a probit and logitistic regressions were selected as the best statistical methods available 
for uncovering the relationships of interest.  
  Of the sample, fully 75.2 percent (802 people) indicated that they support the use of 
biotechnology in agriculture and food production, while 17.2 percent (183 individuals) were in 
opposition.  The remaining 82 respondents indicated that they had not formed an opinion on the 
matter (coded as “don’t know”), or chose to refrain from answering the question (coded as 
“won’t say”).  It is worth noting that the latter two response categories were not among those 
offered as part of the survey instrument, but rather were volunteered by the participants.   
  The decision was made to drop from the analysis, cases in which participants provided 
either a “don’t know” or a “won’t say” response.  This was done because individuals who did not 
indicate a definite position on the matter were deemed unlikely to be of use in the current 
endeavor.  In short, the motivations underlying either support or opposition were of interest, 
while factors leading to indecision or refusal to respond were not.   Further, it is unlikely that the 
resulting reduction in sample size was detrimental to the integrity of the analysis.  The number of 
individuals dropped amounted to just 6.6% of the sample and therefore, did not compromise the 
integrity of the chosen statistical techniques. 
  Several knowledge-related questions focused on ascertaining people’s basic familiarity 
with biotechnology, as well as their perceptions of how well informed they were about related 
subject areas.  Early in the survey instrument, individuals were asked if they had ever heard of   17
biotechnology applications in food production and agriculture.  Participants also rated how well 
informed they were about issues related to new technologies, new scientific discoveries and 
agriculture.
9  These measures of awareness were converted into dummy variables for inclusion in 
the models (called “informtech,” “informsci” and “informag,” respectively).
10  
  Two questions related to the sources of respondents’ knowledge of biotechnology and 
GM foods were also included.  Survey takers were asked whether they had read anything about 
the use of biotechnology in food production.
11   In addition, participants were asked whether they 
had discussed issues related to biotechnology with a friend or colleague.
12   
A measure of educational attainment was also included.  Respondents who had received a 
baccalaureate or post graduate degree were specified by the variable “college.”  This 
categorization is identical to that employed by James, which was found to be an important 
contributor to respondents’ feelings of trust in GM foods. (James, 2003) 
  The independent variables discussed thus far, while arguably relevant in this attempt to 
determine the role of knowledge in shaping people’s feelings of support, fall short of conveying 
their levels of understanding of the science behind genetically modified crops.  To capture this 
dimension of knowledge, two mutually-exclusive scales were constructed, both of which were 
based on a series of six questions that tested respondents’ understanding of DNA, heredity, and 
related subjects.
13  One scale (“correctscale”) measured the number of correct responses given by 
each participant, the other (“dontknowscale”) measured how many times they responded that 
they “don’t know,” or “won’t say” the answer. 
  Given the large number of independent variables related to knowledge, and the resulting 
loss of degrees of freedom within the model of support, the decision was made to reduce the data   18
by performing a factor analysis.  A total of three factors were retained, and the associated factor 
scores used to create three continuous knowledge variables for incorporation into the model in 
place of the nine original measures.  The varimax rotated solutions (rather than their unrotated 
counterparts) were selected for inclusion in the model because, while both are equivalent with 
regard to the amount of variation in the original variables which is explained, the rotated version 
lead to a more even distribution of loadings across the extracted factors, and allowed for some 
interesting relationships between the original variables to be discerned. (See Table 1, Appendix 
B) 
  “Correctscale” and “dontknowscale” loaded most heavily on the first factor extracted.   
The magnitudes of the loadings, while approximately equal in absolute terms, were opposite in 
sign, testifying to the inverse relationship between the number of times one provides a correct 
response as compared to choosing the “don’t know/won’t say” response category. The new 
variable created from this factor was called “testable,” to reflect the fact that it was primarily 
based upon respondents’ ability to answer the true/false science questions.   The second factor 
consisted primarily of “readbiotech,” “talk,” “college” and “heard.”  Since all of these variables 
relate to encounters with, and/or sources of information about biotechnology, the resulting 
variable was called “exposure.”  The three original variables that measured how informed 
respondents felt about related subject areas (“informtech,” “informsci,” and “informag”) loaded 
primarily on factor three, which was subsequently dubbed “informed.”  Given the conflicting 
nature of previous findings regarding the effect of knowledge on levels of support for GM foods, 
it was not clear at the outset whether coefficients associated with the newly constructed variables 
would be positive or negative in sign.   19
  To measure the effect of trust on support for GM foods, some have chosen to construct 
measures based upon people’s conceptions of issues thought relevant to trust formation, such as 
perceptions of personal benefit and risk. (James, 2003)  The U.S. Biotechnology Survey 
however, included a set of questions which directly queried respondents about their trust in 
information provided by a variety of relevant sources, hence their responses were thought to 
provide the most appropriate measures of such sentiments.   
The series of seven questions focused on gauging trust all made use of the same structure, 
namely: “Would you have a lot of trust, some trust, or no trust in a statement made by (name of 
organization) about biotechnology?”  Responses were coded according to the source to create 
seven unique variables: “trusttv” (television news), “trustusda” (U.S. Department of 
Agriculture), “trustmanufacturers” (food manufacturers), “trustscientists” (scientists and 
university professors), and “trustfda” (Food and Drug Administation).  
  As with the measures of respondents’ knowledge, a factor analysis was performed on the 
trust variables.  Two factors were extracted and, as before, the varimax rotated results were 
preferred.   While in the original (unrotated) solution, all of the trust variables had their highest 
loadings on Factor 1, the rotated version distributed the loadings somewhat more evenly, with 
“trustscientists,” “trusttv” and “trustmanufacturers” loading predominantly onto Factor 2. (See 
Table 2, Appendix B)   
  The new variable created from the first factor was called “trustgov,” to reflect the fact 
that the variables measuring trust in information provided by the two government agencies (the 
USDA and the FDA) loaded most highly there.  The variable created from the second factor, 
therefore, included all of the non-governmental information sources, and was titled   20
“trustnongov.”  Before running the regressions, it was thought that both trust variables would be 
positively related to support, that is, as trust increases, so to does support.  
  In addition to knowledge and trust, risk is often thought to influence people’s support for 
new technologies.  As mentioned previously however, perceptions of risk do not appear to be 
neatly defined within the human mind, but instead act to influence, and in turn are influenced by, 
a wide variety of other factors.  In light of this conceptual common ground, risk was included in 
the model of support in two different ways.  First, a dummy variable (“risk”) was created using 
survey takers’ responses to the question, “The use of biotechnology in food production and 
drinks is risky for society.  Do you definitely agree, tend to agree, tend to disagree, or definitely 
disagree?”
14 
  An instrumental variable was also created to measure people’s risk perceptions by 
running a logistic regression on the “risk” variable.  The results were then used to create a new 
continuous variable, “riskinstrument,” which was subsequently entered into the model in place of 
the dummy variable.  While this procedure produced a measure that was considerably less 
powerful than the “risk” variable (pseudo r^2=0.0819), it was done in order to control for 
potential correlations between the error terms of the risk variable and those related to trust, 
perceived benefits, and the other measures included in the model. (See Table 4, Appendix C)
 
  Consideration of benefits is also an important contributor to feelings of support, and to 
discern its influence with regard to GM foods, a variety of predictor variables were selected for 
inclusion in the model.  As before, a factor analysis was performed both for data reduction 
purposes and to discern any underlying relationships between the included variables.  Two 
unique factors were extracted, and the rotated solutions were preferred, largely because they   21
acted to create two distinctive categories: benefits to one’s self and family (realized or 
anticipated), and future benefits to others. (See Table 3, Appendix B)  These results support the 
notion that personal benefits are fundamentally different than those directed towards other 
people, and may have differing impacts on support for GM products.  
Responses to the question of whether participants agreed with the statement; “My family 
and I have already benefited from biotechnology.” were used to create the variable 
“currentpersonalbenefit,” while “futurepersonalbenefit” measured whether participants 
anticipated benefits accruing to people like them as a result of biotechnology within the next 5 
years.  Both variables loaded primarily on a single factor, which was subsequently called 
“personalbenefits” and included in the final regression analysis.   
Three variables were concerned with measuring the benefits that survey takers thought 
would impact others (the poor, other nations and future generations). “Reducepollution” 
reflected whether they felt that the technology would lead to reduced levels of pollution in the 
next 20 years, “reducehunger” indicated whether they anticipated a reduction in world hunger 
over the same time period, and “conserveresources” recorded their feelings as to whether 
biotechnology would help conserve resources in third world countries.   All of these predictors 
were characterized by substantial loadings on the second factor, later named “othersbenefits.”   
  At the outset, it was anticipated that both the “personalbenefits” and the “othersbenefits” 
variables would be associated with an increase in respondents’ support of GM foods (produce 
positive coefficients).  While one can hardly argue with the tendency to support something from 
which one stands to benefit, there is also research that suggests that the public is highly   22
concerned with this technology’s propensity to alleviate burdens (such as hunger) in developing 
nations. (Beckwith et al., 2003) 
  The variable “male” was included in the analysis to determine what, if any, difference 
there would be in levels of support between males and females.  Given the findings of previous 
research, the expectation was that this measure would yield a positive coefficient, reflecting the 
fact that males are more supportive than females. 
The effect of the perceived moral acceptability of biotechnological applications in 
agriculture and food production on levels of support was also explored.  Respondents were asked 
to indicate whether they agreed with the statement that “the use of biotechnology in the 
production of food and drinks is morally acceptable for society,” responses were used to create a 
dummy variable (“moralacceptability”).
15  Before running the model, it was expected that those 
who perceived GM crops to be morally acceptable would display higher levels of support.  
A variable representing political party affiliation, specifically whether respondents 
identified themselves as republican (“republican”), was chosen to represent their ideological 
perspective.  Since low levels of liberal ideology have already been shown to be associated with 
increased levels of support, it was anticipated that self-reported republicans would be more likely 
to support this use of biotechnology than would others. 
  A variable measuring whether respondents identified themselves as Catholic (“catholic”) 
was also included in the model of support.  Membership in almost any religion could arguably 
have an impact on one’s acceptance of GM foods, however, to date the Catholic Church is the 
only religious body to speak out on the issue.  The expected relationship between participation in 
the Catholic Church and levels of support for GM foods was unclear before the analysis was   23
conducted however, because while church officials have spoken out about the technology, they 
have not taken a consistent position of either support or opposition.  On several occasions, 
religious leaders have expressed disapproval of industry’s use of life patents, stating that such an 
appropriation of life was morally and ethically wrong.  Pope John Paul II however, spoke in 
favor of the technology based upon its potential to supply food for the needy. (Warner, 2000)  To 
the author’s knowledge, previous attempts to discern the motivating factors behind feelings of 
support for GM foods have not specifically considered the influence of religion, a fact which 
further underscored the uncertainty regarding its impacts. 
Results 
  Due to the categorical nature of the dependent variable, and the fact that just two 
response categories were available (“support” and “oppose”), probit and logistic regressions 
were chosen as the techniques of choice for use in determining the relationship between 
respondents’ personal characteristics and beliefs, and their support for the use of biotechnology 
in agriculture and food production.  The analysis was run twice, once using the dummy variable 
“risk,” and once using the instrumental variable “riskinstrument.”  “Riskinstrument” was 
associated with a statistically significant coefficient in the resulting equation, a fact which 
indicates that the original measure of risk suffered from some degree of endogeneity and hence, 
should not be included in the analysis.    The model which included “riskinstrument” was found 
to be statistically significant (probit chi
2= 151.79, logit chi
2=132.99), and did a fairly good job of 
explaining the variation in support across participants (probit r
2=0.3473, logistic r
2=.3513). (See 
table 5.)   24
Table 5. Determinants of Support for Genetically Modified Foodstuffs: 























riskinstrument  -3.695975 0.000  -6.791918  .0011228  0.000  N/A 
othersbenefits  -0.04988003 0.669 -0.088893  0.9149435  0.676  N/A 
personalbenefits  0.5617046 0.000 1.020156  2.773626  0.000  N/A 
trustgov  -0.12140454 0.364 -0.2633424  0.7684787  0.274  N/A 
trustnongov  0.37253306 0.039 0.6903971  1.994507  0.038  N/A 
testable  0.11672854 0.091 0.1759743  1.192407  0.151  N/A 
exposure  0.41990513 0.000 0.7661922  2.151558  0.000  N/A 
informed  -0.05719669 0.517 -0.0911625  0.9128694  0.569  N/A 
catholic  0.31799114 0.033  -0.5430434  0.5809774  0.042  -0.0903 
republican  0.0796872 0.117  0.1673195  1.182132  0.069  0.0594 
male  0.15169948 0.276 0.3030795  1.354022  0.224  0.0384 
moralacceptability  0.36468976 0.012 0.6552792  1.92568  0.015  0.0735 
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Of the independent variables incorporated into the regressions, the measures of risk 
(“riskinstrument”), personal benefits (“personalbenefits”), trust in information provided by non-
governmental sources (“trustnongov”), measures of exposure to information on the subject 
(“exposure”), Catholicism (“catholic”), Republicanism (“republican”) and moral acceptability 
(“moralacceptability”) were found to be significant at the p=0.05 level or greater using the most 
stringent (two-tailed) test of statistical significance.  Of these, the coefficients associated with 
risk and Catholicism were negative in sign, indicating that individuals who believe the use of 
biotechnology in food production to be risky, as well as those who identify themselves as 
Catholic, are less likely to be supportive of this technological application than those who do not 
have these characteristics.   
The relationship between risk and support is hardly surprising; it is in agreement with 
previous findings and arguably, with common sense.   The conclusion that Catholics are less 
likely to support GM foods than non-Catholics is not so clear-cut, however.  While it indicates 
that some denomination-specific reasoning is influential in reducing support in this regard, 
judgments do not appear to be based entirely around perceptions of morality (as evidenced by the 
relatively low correlation (0.0274) between “catholic” and “moralacceptability”).  The effect of 
this religious affiliation is noteworthy, however, as indicated by the fact that, all else equal, the 
likelihood of supporting GM foods is nine percentage points lower among Catholics than non-
Catholics, a fact which highlights the need for more focused research on the subject. 
  Despite previous claims that people consider benefits to humankind as a whole in 
deciding whether to support GM foods, the results of this analysis indicate that only benefits 
reaped by the individual and their families influence levels of support.  The coefficient   26
associated with “personalbenefits” is positive in sign, thus, as expectations of personal benefits 
increase, so to do levels of support for GM foods.   
The fact that people’s expectations of benefits accruing to others as a result of the use of 
biotechnology were not influential over their levels of support for such applications is quite 
telling.  It is possible that goals such as reducing world hunger and conserving natural resources 
are considered unimportant by the average American and therefore, did not influence their 
feelings of support.  It may also be that, as was observed in a previous study involving Danish 
participants, such aims were considered in the valuation process but significant doubts existed as 
to whether they would ever be realized, leading people to discount their importance. (Beckwith 
et al., 2003)  Before concluding that members of the American public are exclusively interested 
in improving their own wellbeing, therefore, more in-depth research on the subject is warranted. 
  While trust in information provided by governmental sources was not found to be a 
significant determining factor in respondent’s support of GM technology, their trust in 
information provided by non-governmental sources, including television, food manufacturers 
and scientists, was relevant.  As was expected, the coefficient associated with trust in 
information was positive in sign.   
It is unclear, however, why trust in information from one set of sources should be 
important and the other not.  One possible explanation is that the varying levels of participation 
these groups have had in the public debate on the subject of GM crops accounts for this finding.  
Thus far, information on the subject has primarily been generated by industry and university 
scientists, and disseminated to the public via television and other forms of mass media.  
Regulatory agencies, on the other hand, have remained largely absent from the public debate on   27
the subject and, as described previously, chosen to treat products created using genetic 
engineering as they do their conventionally-derived equivalents.  These differential levels of 
involvement may impact respondents’ perceptions. (Besely et al., 2005; Frewer et al., 1997; 
Nisbett et al., 2001) 
  The “exposure” variable was also highly significant and produced a positive coefficient, 
indicating that those who had heard of using biotechnology in food production, had attained a 
baccalaureate or post-graduate degree, and/or had read or talked with someone about 
biotechnology, were more likely than others to be supportive of GM foods.  These findings 
demonstrate that members of the public who are highly educated, as well as those who are more 
familiar with the subject matter, tend to view biotechnology in a more positive light than do their 
less educated, less informed counterparts.  People’s judgments as to how informed they were 
regarding scientific and technological issues were clearly not influential on their feelings in this 
matter, however, their level of knowledge (as measured by the series of true/false questions 
related to genetics) was somewhat important, and had the effect of increasing support.
16  Taken 
together, these results seem to indicate that the more people know about biotechnology, the 
greater their support for it. 
  Republican respondents were about 1.18 times more likely to be supportive of the use of 
biotechnology in agriculture and food production than were non-Republicans.  This finding is in 
agreement with the claim that more liberal-minded individuals are less approving of such 
endeavors, and although the studies consulted in preparation for the current analysis did not 
specifically explore the influence of political party affiliation, it appears that it is in fact, an 
important predictor of support.     28
  It is not altogether clear why Republican participants viewed GM foods more positively 
than did others; none of the political parties appear to have adopted a definitive stance with 
regard to biotechnology.  It may be that certain characteristics of the industry, and of its 
regulation in the U.S., such as the existence of minimal federal oversight and substantial reliance 
upon market forces, are more in-line with Republican ideology than with the views of Democrats 
and others.   
  Another important determinant in respondents’ levels of support for GM foods was their 
feeling as to whether such technological applications were morally acceptable.  Those who did 
not object to such process on moral grounds were nearly twice as likely (as indicated by the odds 
ratio of 1.93) to indicate their support for the use of biotech in food production.  This finding is 
in agreement with previous research which indicated the importance of ethical considerations to 
feelings of support.  
  In some respects, the lack of explanatory power associated with certain variables is as 
enlightening as the significance of others.  The high p-value (0.276 for both the logitistic 
regression and probit) associated with the variable “male” in the current analysis provides 
evidence that, contrary to previous assertions, gender has no discernable effect on people’s 
feelings of support or opposition to GM foods.  Given that this conclusion has been reached 
before (see James, 2003), it is somewhat surprising that some of the literature still purports such 
a divide to be a tangible reality and worthy of consideration, while at the same time failing to 
investigate the influence of such factors as political party and religious affiliation.    
Conclusions   29
  In the United States, genetically modified foods (and foods containing GM ingredients) 
have been deemed substantially equivalent” to products derived through traditional cross-
breeding techniques, and levels of development, cultivation, sales and consumption far outpace 
those occurring in any other nation.  Despite this, little public debate on the subject has occurred 
and the average citizen remains largely uninformed regarding biotechnology and the products it 
yields.  Thus far, Americans’ reactions have been far less negative than those witnessed abroad, 
yet it is not altogether clear how much support actually exists for this technology.  Even less 
certain are the nature and the relative importance of factors which inspire one to adopt a position 
of either support or opposition to the use of biotechnology in agriculture and food production. 
The analysis presented here built upon the work of previous researchers in trying to 
discern the role of knowledge, trust, perceptions of risks and benefits, moral acceptability, 
political identity and religiosity in influencing levels of support for GM foods.  To facilitate the 
examination of a large number of independent variables, a series of three factor analyses were 
performed (one focused on knowledge, one on trust and one on benefits) to reduce the amount of 
data, thereby saving degrees of freedom, as well as to assist in discerning the underlying 
relationships that exist between the original measures.  The issue of risk perception, although 
arguably quite influential in determining levels of support, shares a good deal of conceptual 
common ground with many of the other factors thought to be influential in this regard.  To 
account for any correlation in the error terms across the right hand side variables, an instrumental 
variable measuring risk was created and incorporated into the model. 
The analysis revealed that a variety of factors were important in predicting whether 
respondents supported or opposed GM foods.  High levels of perceived risk were found to   30
appreciably increase the likelihood that a person would oppose this technology.  However, 
knowledge acquired through exposure to the subject matter had a significant positive effect on 
support, as did trust in information provided by non-governmental sources, and the expectation 
that the technology would yield benefits for one’s self or one’s family.  Republicans were found 
to be more supportive than those professing other political party affiliations, however, Catholics 
were less supportive than members of other faiths and the non-religious.  Finally, those who felt 
that GM foods were morally acceptable were more likely to indicate their support than were 
individuals who felt otherwise.  Benefits expected to accrue to others (people other than the 
respondents and their families) were not significant in determining levels of support, and trust in 
information provided by governmental sources, knowledge as measured by a set of six true/false 
questions about genetics and heredity, perceptions of how informed one is regarding issues 
related to biotechnology and respondents’ gender were similarly unimportant. 
Although for the most part, this analysis acted to replicate and combine the findings of 
previous researchers, the unique treatment and combination of variables considered here allowed 
for the influence of familiar factors, such as risk perceptions and trust, to come together in new 
and interesting ways.  In light of these findings, further research is clearly warranted, especially 
with regard to the role of expected benefits for others, and the influence of people’s religious 
affiliation, on their tendency to support GM foods and biotechnology.  A set of well-designed 
survey instruments could likely do much to further explain the influences and interconnections 
between the factors considered here.  However, one must be careful not to lose sight of the fact 
that the inner workings of the human mind are infinitely complex and unique, and even the most 
expertly-crafted probes are likely too cumbersome to ever fully tease them apart.   31
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Appendix A 
Below are a list of the statements used to test respondents’ knowledge of genetics and 
biotechnology.   
 
1) Genetically modified animals are larger than normal animals. 
 False 
 
2) Humans and chimpanzees have more than half of their genomes in common. 
 True 
 
3) Cloning produces identical offspring. 
 True 
 
4) Only GM tomatoes contain genes, ordinary tomatoes do not. 
 False 
 
5) Eating genetically modified foods can modify human genes. 
 False 
 
6) It is impossible to transfer animal genes to plants. 
 False   34
Appendix B 
 
Table 1: Factor Analysis of Original Independent Variables Measuring Knowledge 
17 
Variables 
Loadings  on 




Loadings  on 





























readbiotech  0.35519 0.26960 0.29198 0.15205 -0.50762 -0.05738 
talk  0.43715 0.26716 0.18242 0.22951 -0.46563 -0.16209 
college  0.30777 0.23873 0.23566 0.13006 -0.43131 -0.06557 
correctscale  0.82072 -0.30631 -0.00072 0.86092 -0.14520 -0.07167 
dontknowscale  -0.75236 0.40221 0.08647 -0.85567 0.00046 0.05595 
informtech  0.28347 0.32861 -0.40010 0.09724 -0.04802 -0.58022 
informsci  0.36806 0.31986 -0.37302 0.17290 -0.09535 -0.58132 
informag  -0.01277 0.08195 -0.08457 -0.04823 0.01176  -0.10755 
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Table 1: Factor Analysis of Original Independent Variables Measuring Trust 
Variables 
Loadings  on 




Loadings  on 















 (Factor 2, 
Rotated 
Solution) 
trusttv  0.38232 0.16234 0.22355  0.35007 
trustusda  0.49578 -0.14721 0.49215 0.15890 
trustmanufacturers  0.43432 0.09896 0.30228  0.32720 
trustscientists  0.38296 0.10608 0.25589  0.30403 
trustfda  0.51568 -0.14096 0.50503 0.17531 
 
 
Table 3: Factor Analysis of Original Independent Variables Measuring Benefits 
Variables 





Loadings  on 















(Factor 2, Rotated 
Solution) 
reducepollution  0.41440 -0.17334  0.42581 0.14304 
reducehunger  0.44195 -0.25209  0.49846 0.10202 
conserveresources  0.45631 -0.11388  0.41809 0.21537 
futurepersonalbenefit  0.49071 0.24264  0.20879  0.50604 
currentpersonalbenefit  0.35297 0.32907  0.04826  0.48015 
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Appendix C 
 











trusttv  -0.0115645 0.947 
futurepersonalbenefit  -0.0299527 0.879 
trustusda  -0.1575039 0.623 
noacc  0.3975011 0.377 
ntvracc  0.5322277 0.180 
vryacc  0.0200978 0.957 
somacc  0.1467564 0.661 
somuse  1.059724 0.004 
vryuse  0.5204733 0.215 
ntvruse  1.491705 0.000 
nouse  1.641044 0.001 
trustmanufacturers  -0.0125099 0.944 
trustscientists  -0.4701046 0.150 
trustfda  -0.4083273 0.141 
asufreg  0.0807219 0.639 
currentpersonalbenefit  0.1315735 0.458 
reducepollution  0.1080192 0.543 
newdis  0.5142499 0.003 
reducehunger  -0.3830194 0.030 











                                                 
1 The USDA regulates GM Crops under the Plant Protection Act, the EPA under the Federal Insecticide, Fungicide 
and Rodenticide Act and the Toxic Substances Control Act, and the FDA under the Federal Food Drug and 
Cosmetics Act.  
2 This consists of a system for cultivation, storage and distribution whereby GM and non-GM products are kept 
separate. 
3 Cloning has been found to be the most controversial, and the application to which there is the greatest degree of 
opposition, genetic testing and other medical applications are the most widely supported, and GM crops are 
associated with fairly high levels of support among members of the public. 
4 “Dread Risk” is concerned with how controllable something is, the dread it inspires, the magnitude of the negative 
effects, the fairness of the distribution of costs and benefits, how catastrophic a negative outcome is expected to be,   37
                                                                                                                                                             
the risk to future generations, whether the risk can be reduced and whether the risk is assumed voluntarily.  In 
considering “unknown risk,” factors such as whether or not the risk is observable, whether those who are exposed to 
it are aware of the danger, whether the effects are delayed or immediate, the newness of the risk, and the degree of 
understanding regarding the risk among scientists. (Slovic, 1987) 
5 The notion of “process” relates to whether the agency in charge of regulating a risk appear to be trustworthy and 
actively involve affected individuals in the decision-making process, or seems arrogant and unwilling to listen to 
public opinion.   
6 The most common engineered traits are herbicide tolerance and pest resistance, both of which are designed to yield 
benefits to farmers. (Pew Factsheet, available at: http://pewagbiotech.org/) 
7 Terrorism, for example, is more dreaded than automobile accidents, and hence may be perceived as posing a 
greater risk despite the fact that many more Americans die in traffic each year than are killed by suicide bombers 
and the like. 
8 Consequences that are concentrated in time and space appear more risky than those which are diffuse but claim the 
same number of victims. 
9 Answers were coded on a ten point scale ranging from “not at all informed” (1) to “very well informed” (10). 
10 Variables were created by assigning a value of one to responses of seven or higher (to indicate that the respondent 
felt informed regarding the subject), zero otherwise.   
11 Entered into the model as “rdbio.” 
12 Entered into the models as “talk.” 
13 For a list of the questions, see Appendix A. 
14 Those who answered that they “strongly agree” or “somewhat agree,” were coded with a one, all others were 
assigned a value of zero for the variable.   
15 Affirmative answers (either “strongly” or “somewhat agree”) were coded as one, zero otherwise.   
16 The p-value associated with “testable,” was derived through a two-tailed test of significance, was equal to 0.151 
(below the normal minimum significance value of p=0.10).  Had a one-tailed test been conducted (that is, had the 
direction of the effect of increased knowledge been postulated in advance), the variable would have been significant 
at the p=0.10 level.  
17 It is interesting to note that in the unrotated solution, “talk” loads most heavily on Factor 1 (with “correctscale” 
and “dontknowscale”).  The rotated solution, in contrast, shifts “talk” to Factor 3 (with “heard” and “rdbio”).  
Hence, with the exception of “informag” (which as its highest loading on Factor 4), the rotated solution depicts the 
relationships between the knowledge variables in the same way as they are grouped in the description on page  
18 The dependent variables included all measures that were to be input into the final logistic regression for support 
that were thought to be in any way correlated with risk perception, namely: the measures of trust which comprised 
the “trust” variable derived through factor analysis (“trsttv,” “trstnih,” “trstama,” “trstusd,” “trstsci,” “trustfm,” and 
“trstfda”), whether they believed that biotechnology would help to reduce pollution (“redpol”), lead to new diseases 
(“newdis”), reduce world hunger (“redhun”), or preserve natural resources in the third world (“thdwrld”) over the 
next 20 years, whether they believed that biotechnology would benefit them personally in the future (“apersben”) or 
was already providing them with benefits (“alrben”), whether they thought that existing regulations were sufficient 
to protect from the risks of biotechnology (“asufreg”), whether this use of technology was morally acceptable 
(“noacc,” “ntvryacc,” “somacc,” “vryacc”  ), and whether or not it was useful ( “vryuse,” “somuse,” “ntvryuse,” 
“nouse”). 